Biomaterials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 130 Pages I Mordor Intelligence
Biomaterials Market Analysis
The biomaterials market size stands at USD 202.37 billion in 2025 and is forecast to reach USD 384.37 billion by 2030, advancing at a 13.69% CAGR throughout the period. Growth gathers momentum from aging?driven procedure volumes, rapid regenerative medicine breakthroughs, and streamlined regulatory pathways. Polymeric materials keep demand buoyant thanks to their adaptability in cardiovascular stents and orthopedic inserts, while waste-derived natural materials expand quickly as circular-economy mandates intensify. North America benefits from 1,041 FDA breakthrough device designations that de-risk commercialization, yet Asia-Pacific outpaces with double-digit growth backed by China's fivefold rise in knee replacements and Japan's induced-pluripotent-stem-cell (iPSC) innovations. Strategic acquisitions-such as Enovis' EUR 800 million purchase of LimaCorporate-underscore vertical-integration moves aimed at buffering raw-material shortages and EU MDR compliance bottlenecks.
Global Biomaterials Market Trends and Insights
Aging population-led surge in joint-replacement volumes
Primary knee arthroplasty volumes in the United States alone are projected to climb 673% by 2030, and Germany anticipates a 55% rise in knee arthroplasties by 2040. Younger and more active patients now represent a majority of candidates, forcing implant developers to prioritize wear resistance and osseointegration longevity. Colombia projects 39,270 lower-limb arthroplasties by 2050, 52.7% of which will involve women, spurring gender-specific biomaterial formulations. The sustained procedure pipeline cushions the biomaterials market against traditional healthcare spending cycles.
Rapid advances in regenerative medicine & 3-D bioprinting
The Canadian government's CAD 72.75 million grant to Aspect Biosystems signals policy confidence in bioprinted tissues, while machine-learning-driven modelling achieves R > 0.999 for shape predictions in 4D scaffolds. FDA clearance of Symvess, the first acellular tissue-engineered vessel, establishes precedent and accelerates clinical translation. As regulatory clarity improves, venture activity spreads to Asia-Pacific, where Japan's iPSC-based corneal epithelial transplants underscore regional competitiveness.
High production & surgical costs of next-gen biomaterials
Inflation and supply chain shocks inflated contract manufacturing costs during 2024, while polytetrafluoroethylene shortages forced insourcing and inventory stockpiling, impairing cash flow for small device makers. Tantalum prices climbed to USD 5,190 per kg in 2023, tightening margins for specialty implant suppliers. EU MDR compliance adds 18-24 months and significant certification costs, prompting 50% of surveyed European firms to trim portfolios.
Other drivers and restraints analyzed in the detailed report include:
Expansion of cardiovascular interventions using bio-stents / Government R&D grants and fast-track approvals for breakthrough implants / Lengthy multi-phase regulatory & clinical validation timelines /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Polymeric materials retained a 40.15% share of the biomaterials market in 2024, dominating cardiovascular and orthopedic uses. Fish-waste collagen and insect-derived chitosan speed natural-material uptake, driving a 14.67% CAGR that challenges polymeric supremacy. Composite hybrids marry metallic strength with polymeric elasticity, meeting load-bearing preferences in younger arthroplasty patients. Shape-memory polymers produced via 4D printing enable scaffolds that conform in vivo, a differentiator for tissue-engineering firms seeking reimbursement premiums.
Natural candidates also benefit from EU circular-economy incentives, accelerating collagen extraction from sardine scales and upcycling crustacean waste. Metallic biomaterials, though vulnerable to tantalum-and-niobium supply risks, remain indispensable in hip prostheses demanding high fatigue resistance. The biomaterials market continues to reward suppliers able to hedge raw-material volatility through recycling and dual-sourcing strategies.
The Biomaterials Market Report is Segmented by Material Type (Metals, Polymeric, Ceramic, Composite, Natural), Origin (Synthetic, Natural), Application (Orthopedic, Cardiovascular, Dental, Wound Healing, Neurology, Plastic Surgery, Tissue Engineering & Regeneration, Others), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).
Geography Analysis
North America held 42.23% of biomaterials market share in 2024, buoyed by 1,041 FDA breakthrough designations and heavy corporate R&D. Established reimbursement and robust surgeon training programs encourage rapid adoption of premium implants signals federal backing for bioprinting ventures.
Europe grapples with MDR bottlenecks-only 4,873 certificates were issued from 14,539 applications in 2023-delaying launches and prompting some manufacturers to withdraw legacy devices. Despite this, Germany expects knee-replacement incidence to climb 55% by 2040, guaranteeing demand once compliance hurdles ease. EU circular-bioeconomy grants also fast-track insect-derived chitosan plants, giving natural materials an early-mover edge.
Asia-Pacific charts the fastest 15.19% CAGR, propelled by China's fivefold jump in knee replacements and Japan's first-in-human iPSC corneal transplants. Even with venture funding down 22% from 2021 highs, the region's medtech sector still targets USD 225 billion in 2030 revenue, encouraging global OEMs to localize manufacturing. South Korea and Australia add capacity through advanced composite printing hubs, while India's growing middle class amplifies volume demand for cost-efficient implants.
List of Companies Covered in this Report:
Johnson&Johnson / Stryker / Medtronic / Evonik Industries / Corbion NV (Purac) / Zimmer Biomet / Covestro / BASF / Celanese Corporation / Invibio (Victrex plc) / DSM Biomedical / Berkeley Advanced Biomaterials / Dentsply Sirona / Carpenter Technology / Collagen Solutions plc / Straumann Group / Organogenesis / Precision Biomaterials Inc. / Wright Medical (now Stryker) / 3M Health Care /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Aging population-led surge in joint?replacement volumes
4.2.2 Rapid advances in regenerative medicine & 3-D bioprinting
4.2.3 Expansion of cardiovascular interventions using bio-stents
4.2.4 Government R&D grants and fast-track approvals for breakthrough implants
4.2.5 Emergence of 4-D stimuli-responsive biomaterials
4.2.6 Circular-bioeconomy push for waste-derived natural biomaterials
4.3 Market Restraints
4.3.1 High production & surgical costs of next-gen biomaterials
4.3.2 Lengthy multi-phase regulatory & clinical validation timelines
4.3.3 Supply-chain volatility for specialty alloying elements (e.g., Nb, Ta)
4.3.4 Environmental scrutiny over synthetic-polymer leachables
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, 2024-2030)
5.1 By Material Type
5.1.1 Metals
5.1.2 Polymeric
5.1.3 Ceramic
5.1.4 Composite
5.1.5 Natural
5.2 By Origin
5.2.1 Synthetic
5.2.2 Natural
5.3 By Application
5.3.1 Orthopedic
5.3.2 Cardiovascular
5.3.3 Dental
5.3.4 Wound Healing
5.3.5 Neurology
5.3.6 Plastic Surgery
5.3.7 Tissue Engineering & Regeneration
5.3.8 Others
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 India
5.4.3.3 Japan
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Rest of South America
5.4.5 Middle East and Africa
5.4.5.1 GCC
5.4.5.2 South Africa
5.4.5.3 Rest of Middle East and Africa
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Johnson & Johnson (DePuy Synthes)
6.3.2 Stryker Corporation
6.3.3 Medtronic plc
6.3.4 Evonik Industries AG
6.3.5 Corbion NV (Purac)
6.3.6 Zimmer Biomet Holdings Inc.
6.3.7 Covestro AG
6.3.8 BASF SE
6.3.9 Celanese Corporation
6.3.10 Invibio (Victrex plc)
6.3.11 DSM Biomedical
6.3.12 Berkeley Advanced Biomaterials
6.3.13 Dentsply Sirona
6.3.14 Carpenter Technology Corporation
6.3.15 Collagen Solutions plc
6.3.16 Straumann Holding AG
6.3.17 Organogenesis Inc.
6.3.18 Precision Biomaterials Inc.
6.3.19 Wright Medical (now Stryker)
6.3.20 3M Health Care
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.